VJHemOnc is committed to improving our service to you

ESMO 2019 | R/R DLBCL challanges: novel therapeutics

VJHemOnc is committed to improving our service to you

Jarrod Longcor

Jarrod Longcor, MA, MBA, Cellectar Biosciences, Madison, WI, discusses the challenges of designing therapies for R/R diffuse large B-cell lymphoma (DLBCL) and these may be overcome. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter